• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 59 of 100
A sign is seen at an AstraZeneca site in Macclesfield
Health
Here’s Why Shares in This Former Pfizer Target Are Tanking
By Fortune Editors and ReutersJuly 27, 2017
Close up of blister packs red pills
Mitsubishi Tanabe Pharma Is Buying Neuroderm in a $1.1 Billion Bid to Expand Its U.S. Business
By ReutersJuly 24, 2017
Cystic fibrosis drug campaign
Health
This Biotech Just Gained Billions in Market Value Thanks to Its Cystic Fibrosis Drug Cocktail
By Sy MukherjeeJuly 19, 2017
FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
Health
FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
By Sy MukherjeeJuly 12, 2017
Sickle Cell Anemia SEM
Health
The FDA Approved the First New Sickle Cell Drug in 20 Years…But It’s Not a Cure
By Sy MukherjeeJuly 10, 2017
Neisseria Gonorrhoeae
Health
‘Smart’ Gonorrhea Is the Latest Threat In a Troubling Superbug Trend
By Sy MukherjeeJuly 8, 2017
View of stethoscope on table in laboratory
Health
Drug and Device Makers Shelled Out $8 Billion to Doctors and Hospitals Last Year
By Sy MukherjeeJuly 6, 2017
White tablets
Commentary
How Expanding Generic Drugs Can Add to America’s Health Care Woes
By Tim Calkins and Bethany CiancioloJuly 6, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli On Trial For Securities Fraud
Finance
Investor In Martin Shkreli’s Fund Says He Made Millions Despite Being Lied To
By ReutersJuly 6, 2017
Two Stories That Help Explain Runaway Drug Prices
Health
Two Stories That Help Explain Runaway Drug Prices
By Clifton LeafJune 30, 2017
Stefano Pessina, Executive Deputy Chairm
Retail
Walgreens Scraps Rite Aid Deal and Will Instead Buy 2,200 Stores for $5 Billion
By Phil WahbaJune 29, 2017
House Oversight Hearing On Prescription Drug Price Increases
Finance
‘Pharma Bro’ Martin Shkreli Begins His Fraud Trial Monday
By ReutersJune 26, 2017
Mylan NV EpiPen 2-Pak medication sits on a table inside a pharmacy in Provo, Utah, U.S., on Wednesday, Aug. 31, 2016.
Health
Will the Newest EpiPen Competitor Steal Even More Market Share from Mylan?
By Sy MukherjeeJune 19, 2017
Pharmaceutical Drug Roundup Inside A Pharmacy
Health
Mylan Shareholders Are Being Advised to Vote Against Board Members and Executive Pay Packages
By ReutersJune 12, 2017
Johns Hopkins Hospital Continues Cancer Research And Treatment
Health
3 Key Takeaways from the World’s Biggest Cancer Conference
By Sy MukherjeeJune 6, 2017
1...
  • 57
  • 58
  • 59
  • 60
  • 61
...100
Most Popular
Success
Jeff Bezos once gave Eva Longoria and the admiral behind Osama bin Laden's capture $100 million—but she says you don't need wealth to give backplaceholder alt text
By Orianna Rosa RoyleOctober 31, 2026
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.